Medivir AB (publ) (STO:MVIR)
1.554
+0.054 (3.60%)
At close: Mar 6, 2026
Medivir AB Market Cap
Medivir AB has a market cap or net worth of 837.10 million as of March 9, 2026. Its market cap has increased by 257.08% in one year.
Market Cap
837.10M
Enterprise Value
726.10M
Revenue
8.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.55
Market Cap Chart
Since April 30, 1999, Medivir AB's market cap has increased from 643.11M to 837.10M, an increase of 30.16%. That is a compound annual growth rate of 0.99%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SynAct Pharma AB | 999.07M |
| Xspray Pharma AB | 1.01B |
| Cantargia AB | 1.02B |
| Infant Bacterial Therapeutics AB | 674.92M |
| Genovis AB (publ.) | 1.10B |
| FluoGuide | 542.80M |
| BioInvent International AB | 1.49B |
| Oncopeptides AB | 431.42M |